Showing 41 - 60 results of 16,144 for search '(((( a larger decrease ) OR ( b largest decrease ))) OR ( ((i large) OR (b large)) decrease ))', query time: 0.81s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51

    Table_1_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.xlsx by Simon Le Gallou (10742601)

    Published 2021
    “…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”
  12. 52

    Image_1_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.pdf by Simon Le Gallou (10742601)

    Published 2021
    “…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”
  13. 53
  14. 54

    Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma by Marijana Nesic (8771654)

    Published 2020
    “…It plays a crucial role in controlling the initiation and progression of hematologic cancers such as leukemia and lymphoma, and it has been reported that diffuse large B-cell lymphoma (DLBCL) fails to express specific cell-surface molecules that are necessary for the recognition and elimination of tumor cells.…”
  15. 55
  16. 56
  17. 57
  18. 58

    Table_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx by Boram Lee (549836)

    Published 2021
    “…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
  19. 59
  20. 60